Hepatobiliary & Pancreatic Diseases International

Scope & Guideline

Exploring breakthroughs in hepatobiliary and pancreatic disease management.

Introduction

Welcome to the Hepatobiliary & Pancreatic Diseases International information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Hepatobiliary & Pancreatic Diseases International, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1499-3872
PublisherELSEVIER
Support Open AccessNo
CountrySingapore
TypeJournal
Convergefrom 2002 to 2024
AbbreviationHEPATOB PANCREAT DIS / Hepatob. Pancreatic. Dis. Int.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressRADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS

Aims and Scopes

The journal 'Hepatobiliary & Pancreatic Diseases International' focuses on advancing knowledge in the fields of hepatology, biliary diseases, and pancreatic disorders. It aims to provide a platform for high-quality research that contributes to clinical practice and improves patient outcomes in these areas.
  1. Liver Diseases and Transplantation:
    The journal emphasizes research on various liver diseases, including hepatocellular carcinoma, liver cirrhosis, and liver transplantation techniques. It aims to improve understanding of disease mechanisms and enhance surgical and therapeutic approaches.
  2. Pancreatic Disorders:
    There is a significant focus on pancreatic diseases, particularly pancreatic cancer and pancreatitis. The journal publishes studies on diagnosis, treatment strategies, and novel surgical techniques related to these conditions.
  3. Biliary Pathology:
    Research on biliary diseases, including cholangiocarcinoma and complications from biliary interventions, is a core area. The journal explores both surgical and non-surgical management options.
  4. Innovative Surgical Techniques:
    The journal highlights advancements in surgical methods, including minimally invasive techniques and robotic surgery, aimed at improving patient outcomes in liver and pancreatic surgeries.
  5. Clinical and Translational Research:
    Emphasizing the bridge between laboratory research and clinical application, the journal encourages studies that translate scientific findings into practical treatments for liver and pancreatic diseases.
  6. Immunotherapy and Molecular Approaches:
    There is a growing interest in the role of immunotherapy and molecular biology in the treatment of hepatobiliary and pancreatic cancers, reflecting modern therapeutic strategies.
The journal has identified several emerging themes that reflect the latest advancements and interests in the fields of hepatology and pancreatic diseases. These trends are indicative of the evolving landscape of research and clinical practice.
  1. Personalized Medicine and Genomics:
    There is an increasing focus on personalized medicine approaches, including genomic profiling and tailored therapies for hepatobiliary and pancreatic cancers, reflecting the trend towards individualized patient care.
  2. Immunotherapy Advances:
    Research on immunotherapy, including checkpoint inhibitors and novel immunotherapeutic strategies, has gained significant traction, highlighting its potential in treating liver and pancreatic cancers.
  3. Artificial Intelligence and Machine Learning:
    The application of AI and machine learning for diagnostics and treatment predictions is on the rise, showcasing innovations in data-driven approaches to hepatobiliary and pancreatic diseases.
  4. Multidisciplinary Approaches to Treatment:
    Emerging themes include collaborative, multidisciplinary approaches to managing complex cases in hepatobiliary and pancreatic surgery, integrating surgical, medical, and supportive care.
  5. Microbiome and Liver Health:
    Research exploring the relationship between the gut microbiome and liver disease is gaining attention, indicating a growing interest in the microbiome's role in health and disease.
  6. Regenerative Medicine and Stem Cell Therapy:
    There is an increasing exploration of regenerative medicine and stem cell therapy as potential treatments for liver diseases, reflecting advancements in biological therapies.

Declining or Waning

While the journal continues to explore a broad range of topics, certain areas of research have shown a decline in focus over recent years. This may reflect shifts in clinical priorities or advancements in treatment methodologies that have rendered some topics less relevant.
  1. Traditional Surgical Techniques:
    There appears to be a waning emphasis on traditional open surgical techniques for hepatobiliary and pancreatic surgeries, as the field increasingly adopts minimally invasive and robotic approaches.
  2. Conventional Imaging Techniques:
    With the advent of advanced imaging modalities and radiomics, traditional imaging methods for diagnosing liver and pancreatic diseases are becoming less prominent in the journal's publications.
  3. Single-Agent Chemotherapies:
    Research focused solely on single-agent chemotherapy regimens for hepatobiliary malignancies has decreased, likely due to the shift towards combination therapies and personalized medicine.
  4. Basic Science Studies:
    There is a noticeable decline in basic science studies that do not directly translate to clinical practice, as the journal prioritizes research with immediate clinical applicability.
  5. Epidemiological Studies without Novel Insights:
    Epidemiological studies that do not provide new insights or advancements in understanding disease mechanisms or treatment are becoming less frequent.

Similar Journals

Korean Journal of Gastroenterology

Championing Breakthroughs in Gastroenterology
Publisher: Korean Soc GastroenterologyISSN: 1598-9992Frequency: 12 issues/year

Korean Journal of Gastroenterology (ISSN: 1598-9992, E-ISSN: 2233-6869), published by the Korean Society of Gastroenterology, has been a premier outlet for research and advancements in the field of gastroenterology since its inception in 1968. This open-access journal, based in South Korea, fosters a global dialogue on gastrointestinal health, embracing contributions from a diverse array of disciplines within medicine. It is currently ranked in the Q4 quartile for miscellaneous medicine and holds a Scopus rank of #323 out of 636 in general medicine, reflecting its commitment to publishing impactful research despite its relatively recent establishment in high-impact metrics. With a continuous publication timeline extending through to 2024, the journal aims to enhance understanding of gastrointestinal disorders and promote innovative treatments, making it an essential resource for researchers, clinicians, and students alike who seek to stay abreast of the latest developments and clinical applications in gastroenterology.

Gut and Liver

Connecting science and practice in digestive health.
Publisher: EDITORIAL OFFICE GUT & LIVERISSN: 1976-2283Frequency: 6 issues/year

Gut and Liver is a prestigious peer-reviewed journal dedicated to advancing the fields of Gastroenterology and Hepatology. Published by the EDITORIAL OFFICE GUT & LIVER in South Korea, this Open Access journal has been disseminating valuable research findings since 2007, making critical knowledge accessible to a global audience. With an impressive 2023 impact factor that places it in Q1 rank in both Gastroenterology (#28/167) and Hepatology (#22/82), it is recognized as a leader in the medical domain. The journal covers diverse topics, including innovative therapeutic strategies, clinical practices, and groundbreaking research in liver diseases and gastrointestinal disorders, thereby playing a vital role in improving patient care and outcomes. Researchers, healthcare professionals, and students can benefit from the journal's wealth of information, designed to foster collaboration and spark new ideas within the scientific community. For further engagement with current research, readers can access issues from 2009 to 2024 and stay updated on the latest advancements in the field.

Annals of Hepato-Biliary-Pancreatic Surgery

Advancing Knowledge for Optimal Patient Outcomes
Publisher: Korean Assoc Hepato-Biliary-Pancreatic Surgery KAHBPSISSN: 2508-5778Frequency: 4 issues/year

Annals of Hepato-Biliary-Pancreatic Surgery is a leading academic journal dedicated to the fields of hepatobiliary and pancreatic surgery, contributing essential research and clinical insights to enhance surgical practices and patient outcomes. Published by the Korean Association of Hepato-Biliary-Pancreatic Surgery (KAHBPS), this journal serves as a vital resource for researchers, clinicians, and healthcare professionals interested in the latest advancements and methodologies within this specialized area. With an ISSN of 2508-5778 and an E-ISSN of 2508-5859, the journal presents a platform for high-quality, peer-reviewed articles that focus on the management and surgical techniques for liver, biliary, and pancreatic disorders. Although it currently offers limited open access options, the journal has been recognized in the 2023 Scopus Ranks, reflecting its influence in the medical community, particularly with a Q3 designation in Gastroenterology and Surgery. By fostering academic dialogue, the Annals of Hepato-Biliary-Pancreatic Surgery plays a crucial role in shaping evidence-based practice, making it indispensable for those engaged in this dynamic and evolving field.

JGH Open

Transforming Discovery into Practice in Gastroenterology
Publisher: WILEYISSN: 2397-9070Frequency: 1 issue/year

JGH Open is a prominent open-access journal dedicated to advancing knowledge in the fields of Gastroenterology and Hepatology, published by WILEY. Since its inception in 2017, the journal has served as a crucial platform for researchers, professionals, and students to disseminate innovative research findings and clinical insights. With an impact factor and Scopus rankings reflecting its steady growth—ranking in the 3rd quartile for both Gastroenterology (Q3) and Hepatology (Q3)—JGH Open is positioned within the competitive landscape of medicine. Its commitment to open access enhances the visibility and accessibility of high-quality research, ensuring that significant advancements in understanding diseases of the gastrointestinal tract and liver reach a broad audience. With a focus on collaboration and dissemination of knowledge, JGH Open aims to contribute to the global discourse and improve outcomes in gastrointestinal health.

Translational Gastroenterology and Hepatology

Fostering Global Collaboration in Gastrointestinal Science.
Publisher: AME PUBLISHING COMPANYISSN: Frequency: 4 issues/year

Translational Gastroenterology and Hepatology, published by AME Publishing Company, stands as a pivotal platform for advancing the understanding and treatment of gastrointestinal and liver diseases. With its focus on translational research, this journal aims to bridge the gap between laboratory discoveries and clinical applications, thus fostering improvements in patient care. Although specific metrics like H-Index and Scopus ranks are currently unavailable, the journal is committed to maintaining high standards of scholarly communication and excellence. As an open-access publication, it ensures that valuable findings are readily accessible to a global audience, promoting collaboration and innovation among researchers, clinicians, and healthcare professionals invested in gastroenterology and hepatology. The journal's dedication to disseminating groundbreaking research makes it an essential resource for those seeking to stay at the forefront of these ever-evolving fields.

HPB

Advancing knowledge in Gastroenterology and Hepatology.
Publisher: ELSEVIER SCI LTDISSN: 1365-182XFrequency: 12 issues/year

HPB is a premier journal dedicated to advancing the fields of Gastroenterology and Hepatology, published by Elsevier Science Ltd. With an impressive impact factor reflective of its high-quality research output, HPB has earned its place as a Q1 journal in Gastroenterology and Q2 in Hepatology as of 2023. The journal, available in both print and electronic formats (ISSN: 1365-182X; E-ISSN: 1477-2574), serves as a vital platform for multidisciplinary research, encompassing clinical and experimental studies, aimed at improving patient care and outcomes related to liver and biliary diseases. Since its inception in 2000, HPB has published influential articles that have shaped practice and policy in the field. Located in the United Kingdom, at 125 London Wall, London EC2Y 5AS, the journal is poised to continue its mission of fostering innovation and collaboration among researchers, healthcare professionals, and academicians worldwide.

Journal of the Pancreas

Advancing pancreatic health through innovative research.
Publisher: E S BURIONI RICERCHE BIBLIOGRAFICHEISSN: 1590-8577Frequency: 6 issues/year

Journal of the Pancreas is a pivotal academic publication dedicated to advancing our understanding of pancreatic diseases and disorders. Published by E S Burioni Ricerche Bibliografiche, this journal aims to disseminate novel research findings, case studies, and reviews pertaining to the diagnosis, treatment, and management of pancreatic conditions. With its ISSN 1590-8577, the journal has made significant contributions to the medical field since its inception in 2000, although it ceased its coverage in Scopus in 2015. The Journal of the Pancreas is particularly valuable for researchers, healthcare professionals, and students in gastroenterology and related fields, as it supports evidence-based practices and promotes collaboration in the exploration of pancreatic health. The importance of this journal is underscored by its commitment to providing high-quality, peer-reviewed research that informs clinical approaches and enhances patient outcomes.

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS

Pioneering research for a healthier digestive future.
Publisher: ARAN EDICIONES, S AISSN: 1130-0108Frequency: 12 issues/year

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, a pivotal Open Access journal published by ARAN EDICIONES, S A, has been at the forefront of advancing the field of gastroenterology since its inception in 1990. With a robust commitment to disseminating high-quality research, the journal provides a platform for researchers, clinicians, and students to share innovative findings and insights concerning digestive diseases. The journal is characterized by its Q3 ranking in both Gastroenterology and Miscellaneous Medicine categories, indicative of its significant contributions to these fields, and is positioned within the 36th percentile of Scopus rankings for medicine related to gastroenterology. Based in Spain, REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS has embraced the Open Access model since 2004, ensuring that its articles are readily available to a global audience without financial barriers. The journal not only supports academic discourse but also plays a crucial role in improving clinical practices and health outcomes related to digestive health.

Gastroenterologia y Hepatologia

Empowering healthcare professionals with high-quality research.
Publisher: ELSEVIER ESPANA SLUISSN: 0210-5705Frequency: 10 issues/year

Gastroenterologia y Hepatologia, published by Elsevier España SLU, is a distinguished journal dedicated to advancing the fields of gastroenterology and hepatology. With a publication history spanning from 1982 to 2024, this journal is recognized for its commitment to disseminating high-quality research and reviews that address critical developments in the diagnosis and treatment of gastrointestinal and liver diseases. Although it currently ranks in the Q3 quartile in both gastroenterology and hepatology based on the 2023 metrics, the journal continues to attract a global audience of researchers, healthcare professionals, and students eager to engage with the latest findings. The journal is accessible in both print and electronic formats (ISSN: 0210-5705), making its valuable insights reachable to a broad spectrum of subscribers. By fostering a platform for rigorous scholarly communication, Gastroenterologia y Hepatologia plays a vital role in shaping the future of research in these essential medical fields.

United European Gastroenterology Journal

Leading the way in gastrointestinal health innovation.
Publisher: JOHN WILEY & SONS LTDISSN: 2050-6406Frequency: 6 issues/year

The United European Gastroenterology Journal, published by John Wiley & Sons Ltd, is a leading publication in the fields of gastroenterology and oncology, boasting a distinguished Q1 ranking in both categories for 2023. With an ISSN of 2050-6406 and an E-ISSN of 2050-6414, this journal serves as a vital platform for disseminating cutting-edge research and innovative practices from 2013 to 2024, supporting the advancement of knowledge in gastrointestinal health and cancer treatment. With a commendable Scopus Rank of 14th out of 167 in gastroenterology and 54th out of 404 in oncology, it emphasizes the significance of impactful research in these critical areas. While currently not an open-access journal, it remains a vital resource for researchers, professionals, and students seeking comprehensive insights and evidence-based approaches to improve patient care and clinical outcomes. The United European Gastroenterology Journal is committed to bridging the gap between research and practice, making it an essential reference for those dedicated to the fields of gastroenterology and oncology.